Perspective Announces Merck Collaboration to Test [212Pb]PSV359 with Keytruda in FAP-α Tumors
Perspective announced a clinical collaboration with Merck to evaluate [212Pb]PSV359 combined with Keytruda in FAP-α positive solid tumors.Key Highlights:Original SEC Filing: Perspective Therapeutics, Inc. [ CATX ] - 8-K - Sep. 14, 2026This is an AI-powered summary. It may contain inaccuracies. Cons…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.